NEW YORK (GenomeWeb) – Investment bank Cowen today initiated coverage of NanoString Technologies.

In a research note, analyst Doug Schenkel gave shares of NanoString an Outperform rating with a price target of $20 per share.

"We view the risk/reward as compelling given the track record, predictable growth model, and upside sources," he said.  Over the next two to five years, NanoString can generate sales growth "exceeding most other companies in the group, and the growth outlook is relatively predictable given the company's razor/blade model," Schenkel said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.